Cite
Baicalin Inhibits NLRP3 Inflammasome Activity Via the AMPK Signaling Pathway to Alleviate Cerebral Ischemia-Reperfusion Injury.
MLA
Zheng, Wen-Xia, et al. “Baicalin Inhibits NLRP3 Inflammasome Activity Via the AMPK Signaling Pathway to Alleviate Cerebral Ischemia-Reperfusion Injury.” Inflammation, vol. 44, no. 5, Oct. 2021, pp. 2091–105. EBSCOhost, https://doi.org/10.1007/s10753-021-01486-z.
APA
Zheng, W.-X., He, W.-Q., Zhang, Q.-R., Jia, J.-X., Zhao, S., Wu, F.-J., & Cao, X.-L. (2021). Baicalin Inhibits NLRP3 Inflammasome Activity Via the AMPK Signaling Pathway to Alleviate Cerebral Ischemia-Reperfusion Injury. Inflammation, 44(5), 2091–2105. https://doi.org/10.1007/s10753-021-01486-z
Chicago
Zheng, Wen-Xia, Wen-Qi He, Qian-Rui Zhang, Jin-Xin Jia, Sheng Zhao, Fang-Jian Wu, and Xiao-Lu Cao. 2021. “Baicalin Inhibits NLRP3 Inflammasome Activity Via the AMPK Signaling Pathway to Alleviate Cerebral Ischemia-Reperfusion Injury.” Inflammation 44 (5): 2091–2105. doi:10.1007/s10753-021-01486-z.